In well-nourished adults, the large trials have mostly not found that a daily multivitamin prevents cancer, heart disease, or early death. It is one of the cheapest supplements on the shelf.
Its value is narrower than its reputation: it fills a specific dietary gap where one exists, and does little where a diet already meets the requirement.
Findings & Outcomes
What It Is
The multivitamin is the world's most-taken supplement. One daily pill holds 12 or more vitamins and minerals, each at about a day's requirement. It is cheap, with a long safety record at everyday doses. The logic is insurance: cover any small shortfall a diet might leave. That logic holds where a shortfall exists. The large randomized trials tested the bigger claim, that topping up an already well-fed adult prevents disease, and mostly found no benefit.
Anatomy of the Practice
1A broad, low-dose blend
A multivitamin spreads its coverage wide and keeps each dose low, with every nutrient set at about the daily requirement, roughly 100% of the RDA, not several times it. It aims to fill small gaps across the board, not to deliver a large therapeutic dose of any single nutrient.
2Two classes of nutrient
The blend holds two kinds. Water-soluble vitamins, like C and the B group, wash out in the urine when they run high, so a surplus is hard to reach. The fat-soluble vitamins A, D, E and K store in the body instead. That storage is why those few carry upper limits worth respecting.
3Value tracks the size of the gap
Where a real deficiency exists, correcting it restores function and can prevent disease. Where intake is already adequate, there is no deficit to correct. The clear benefits show up in people who were short of a nutrient; the well-fed gain little.
How It Works
A multivitamin works by correcting a shortfall. Each vitamin and mineral acts as a cofactor the body uses to build tissue, carry oxygen, clot blood, fire nerves, and run metabolism. Fall short of one, and whatever depends on it stalls; restore it, and the process resumes. The response follows a threshold. Below the daily requirement, adding a nutrient helps a great deal. At or past 100% of it, adding more does little, because the surplus is stored or passed out.
What Changed
For years the advice was blanket: everyone should take one, a small hedge no one would regret. Observational studies made it easy to believe: supplement-takers were healthier. But those same people also exercise more, eat better, and see a doctor sooner. The healthier habits, not the pill, explained the difference. Then the large randomized trials reported. The Physicians' Health Study II followed 14,641 men for more than a decade. A daily pill produced a modest, borderline drop in total cancer, its confidence interval nearly reaching no effect. It moved nothing measurable for heart attack, stroke, or cardiovascular death. The 2022 review behind the US Preventive Services Task Force pooled 84 studies in more than 700,000 people. It found little to no benefit for preventing cancer, cardiovascular disease, or death in a well-nourished adult population.
The value was never in disease prevention; it was in filling a specific shortfall. A newer line of research adds one open question: a possible lift in memory among older adults, not yet pinned down. The trials behind it are small and unreplicated, so the memory effect is not established.
In a well-nourished adult, the daily pill does little or nothing to lower the risk of cancer, heart disease, or early death.
Ways to Do It
A varied diet covers the nutrients most people need. The real question is only whether you fall into one of the few groups with a gap to fill.
A varied whole-food diet (vegetables, fruit, legumes, whole grains, fish, eggs or lean meat) supplies the vitamins and minerals most people need. For someone eating this way most of the time, a multivitamin has little left to fill. Build the diet first.
The value of a multivitamin is for specific situations. A vegan or strict vegetarian diet runs short on B12, and sometimes iron and zinc. Malabsorption conditions (celiac disease, inflammatory bowel disease, or a history of bariatric surgery) reduce uptake across the board. Older adults absorb and make less B12 and vitamin D. Very limited sun exposure lowers vitamin D. If one of these fits you, filling the gap is where a supplement earns its place.
This is the one clearly proven prevention benefit. Folic acid taken around conception sharply cuts the risk of neural-tube defects such as spina bifida. That is why prenatal folate is standard advice for anyone who may become pregnant. Here the gap is specific and the timing is early: before and in the first weeks of pregnancy.
For someone who wants the cover without a specific deficiency, a basic generic multivitamin at around daily-requirement amounts is a cheap, reasonable choice. Premium formulas and megadoses raise the dose without adding evidence of benefit.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Fertility
Folic acid around conception cut neural tube defects 72% in high-risk women (MRC)
Taking folic acid around the time of conception sharply reduced the risk of neural tube defects such as spina bifida in women who had already had an affected pregnancy, by about 72 percent. This is the clearest case where a supplement, filling a specific gap at a specific time, prevents disease.
The Medical Research Council Vitamin Study randomized 1817 women at high risk of a neural tube defect pregnancy (because of a previous affected pregnancy) across 33 centers in seven countries to folic acid, other vitamins, both, or neither, around the time of conception. Among 1195 completed pregnancies with a known outcome, folic acid produced a 72% protective effect against neural tube defect recurrence (relative risk 0.28, 95% CI 0.12 to 0.71). The other vitamins showed no significant effect (RR 0.80). This trial is the basis for the standing recommendation that women who may become pregnant get adequate folic acid, and it anchors the principle that supplementation delivers when it fills a well-defined gap.
The study · 1
Heart And Vascular
A daily multivitamin did not lower cardiovascular events or deaths in men over 11 years (PHS II)
In the same large trial of male physicians, a daily multivitamin made no measurable difference to heart attacks, strokes, cardiovascular deaths, or deaths from any cause over more than a decade.
In the cardiovascular arm of the Physicians' Health Study II (14,641 men, median 11.2 years), a daily multivitamin had no significant effect on major cardiovascular events (11.0 vs 10.8 events per 1000 person-years; HR 1.01, 95% CI 0.91 to 1.10, P=0.91). It also did nothing for total myocardial infarction (HR 0.93), total stroke (HR 1.06), or cardiovascular mortality (HR 0.95), and was not significantly associated with total mortality (HR 0.94, 95% CI 0.88 to 1.02, P=0.13). The result speaks to a well-nourished population, where a broad low-dose supplement had little cardiovascular process left to change.
Who this may not transfer to:Men only; a clean null for cardiovascular events in men, and while there is no strong reason to expect a benefit in women that the trials missed, the finding was not measured in women here.
The study · 1
Sesso 2012, JAMA (Physicians' Health Study II, cardiovascular) · JAMA
Cancer Risk And Outcome
A low-dose antioxidant blend did not cut cancer, heart disease or death overall, only cancer in men (SU.VI.MAX)
A French trial of a low-dose antioxidant vitamin-and-mineral blend found no overall benefit for cancer, heart disease or death, but when split by sex it lowered cancer in men and not in women, likely because the men started with lower nutrient levels.
The SU.VI.MAX trial randomized roughly 13,000 French adults to a daily low-dose combination of antioxidant vitamins and minerals (vitamin C, vitamin E, beta-carotene, selenium, zinc) or placebo for 7.5 years. Overall there were no significant differences in total cancer (4.1% vs 4.5%), ischemic cardiovascular disease (2.1% vs 2.1%) or all-cause mortality. A significant sex interaction emerged for cancer (P=0.004): a protective effect in men (RR 0.69, 95% CI 0.53 to 0.91) but none in women (RR 1.04, 95% CI 0.85 to 1.29). The authors attributed the male-only benefit to men's lower baseline antioxidant status, especially beta-carotene, which fits the theme that supplementation helps most where a gap exists.
The study · 1
Hercberg 2004, Arch Intern Med (SU.VI.MAX) · Arch Intern Med
A daily multivitamin lowered total cancer about 8% in older men (PHS II)
In a large trial of male physicians, taking a daily multivitamin for over a decade led to a small drop in the overall rate of cancer, about 8 percent. The effect was modest and borderline, and it did not change deaths from cancer.
The Physicians' Health Study II randomized 14,641 male US physicians aged 50 and over (mean 64) to a daily common multivitamin or placebo, with treatment and follow-up over a median 11.2 years. Men on the multivitamin had a statistically significant reduction in total cancer (17.0 vs 18.3 events per 1000 person-years; HR 0.92, 95% CI 0.86 to 0.998, P=0.04). The upper bound of the interval almost touched 1.0, so the finding is modest and fragile. There was no significant effect on prostate cancer (HR 0.98), colorectal cancer (HR 0.89), or cancer mortality (HR 0.88, P=0.07). This is the one large multivitamin trial to report a total-cancer signal.
Who this may not transfer to:The trial enrolled only men; whether the same modest cancer effect holds in women was not tested here, and a separate French antioxidant trial (SU.VI.MAX) found a cancer benefit in men but not women, so the signal should not be assumed to transfer.
The study · 1
Gaziano 2012, JAMA (Physicians' Health Study II, cancer) · JAMA
Cognition
A daily multivitamin gave older men no memory or thinking benefit over a decade (PHS II)
An earlier trial in older male physicians found that long-term daily multivitamin use gave no measurable benefit to memory or overall thinking, which is why the newer cognition signal is treated as emerging, not settled.
A cognitive substudy of the Physicians' Health Study II assessed 5947 male physicians aged 65 and over with repeated telephone cognitive testing over roughly a decade of multivitamin or placebo use. There was no difference between groups in cognitive change over time or in the level of cognition at any assessment. For the global composite, the mean difference in change was -0.01 standardized units (95% CI -0.04 to 0.02), and verbal memory was likewise unchanged. The authors noted the doses may have been too low, or the population too well-nourished, to benefit. This null in men predates and sits against the later COSMOS signals in older adults.
Who this may not transfer to:Men only; the later COSMOS trials that found a benefit enrolled mostly women, so this null in men and the newer positive signal in a mixed, majority-female sample are not directly comparable, and neither settles the other.
The study · 1
Grodstein 2013, Ann Intern Med (Physicians' Health Study II, cognition) · Ann Intern Med
A daily multivitamin slightly improved global cognition over 3 years in older adults (COSMOS-Mind)
In older adults, a daily multivitamin produced a small but statistically significant improvement in overall thinking and memory over three years compared with placebo, in a trial that was mainly designed to test cocoa extract.
COSMOS-Mind, a 3-year randomized two-by-two factorial trial in 2262 older adults (mean age 73, 60% women), tested cocoa extract and a commercial multivitamin-mineral against placebo, with global cognition by telephone as an outcome. Cocoa extract had no effect (z=0.03, P=0.28), but the multivitamin significantly improved global cognition (mean z=0.07, 95% CI 0.02 to 0.12, P=0.007), with additional benefits for memory and executive function. The effect was most pronounced in participants with a cardiovascular history. This is one of the first randomized signals that a multivitamin may aid cognition in older age, and it is a secondary, not primary endpoint of the trial.
The study · 1
Baker 2023, Alzheimers Dement (COSMOS-Mind) · Alzheimers Dement
A daily multivitamin improved memory in older adults, worth about 3.1 years (COSMOS-Web)
In a large web-based trial, older adults taking a daily multivitamin remembered a word list better than those on placebo. The improvement was estimated to be worth about three years of age-related memory change, though it did not extend to other thinking tests.
COSMOS-Web randomized older adults (analysis n around 3560) to a daily multivitamin or placebo and measured memory with an online recall task. The multivitamin group had significantly better immediate recall at 1 year, the primary endpoint (P=0.025), and across the 3 years on average (P=0.011). Using the cross-sectional relationship between age and recall, the authors estimated the effect equated to about 3.1 years of age-related memory change. There were no significant effects on the secondary cognitive outcomes. Together with COSMOS-Mind, it forms an emerging body of evidence for a modest cognitive benefit in older adults, concentrated in memory.
The study · 1
Yeung 2023, Am J Clin Nutr (COSMOS-Web) · Am J Clin Nutr
Longevity And Mortality
Across 84 studies in 739,803 adults, supplements did little to prevent cancer, heart disease or death (USPSTF)
The large review behind the 2022 US Preventive Services Task Force assessment pooled 84 studies in more than 700,000 people and found that supplements do little or nothing to prevent cancer, heart disease or early death in the general adult population, aside from a small and uncertain cancer signal for multivitamins.
The evidence review commissioned by the US Preventive Services Task Force (O'Connor 2022) synthesized 84 studies in 739,803 community-dwelling, non-pregnant adults. In pooled analyzes, multivitamin use was associated with slightly lower incidence of any cancer (OR 0.93, 95% CI 0.87 to 0.99; 4 RCTs) and lung cancer (OR 0.75; 2 RCTs), but the review flagged important limitations in that evidence. Vitamin D and vitamin E showed no significant effect on all-cause mortality, cardiovascular disease or cancer. The Task Force concluded with moderate certainty that supplementation confers little or no net benefit for preventing cardiovascular disease, cancer or death in the general adult population, and issued an insufficient-evidence statement for multivitamins.
The studies · 2
Older women taking multivitamins had a 2.4% higher death rate, an observational link that cannot show cause
In a long-running study following older women, those who used multivitamins had a slightly higher death rate than those who did not. Because this is an observational study, it cannot show that the supplements caused the difference.
The Iowa Women's Health Study followed 38,772 older women (mean age 62 at baseline) with repeated self-reported supplement use from 1986 through 2008 (about two decades). In multivariable-adjusted models, multivitamin use was associated with a small increase in total mortality (HR 1.06, 95% CI 1.02 to 1.10; absolute risk increase 2.4%), with a stronger association for supplemental iron (HR 1.10, rising with dose) and an inverse association for calcium (HR 0.91). The associations are small, and observational: they cannot establish cause. It is a data point that routine supplement use in older women showed no survival advantage, and if anything a slight adverse association, not proof of harm.
Who this may not transfer to:Women only; whether a similar mortality association appears in men was not studied here, and the randomized trials in men (Physicians' Health Study II) found no effect on total mortality either way.
The study · 1
Mursu 2011, Arch Intern Med (Iowa Women's Health Study) · Arch Intern Med
Go Deeper
- Whole foods: the varied diet a multivitamin is built to stand in for.
- Vitamin D: a single nutrient with the same lesson: correct a real shortfall and it helps, top up a normal level and it does little.
- Omega-3 fish oil: another popular supplement tested in the same large prevention trials.
The Chinese Medicine View
The multivitamin is a modern invention, a concentrate of isolated nutrients that did not exist when the classical Chinese pharmacopoeia was written. No classical text describes it, no channel it enters, no flavor or temperature set by any historical source. The closest idea the tradition offers is the Spleen. In Chinese medicine the Spleen governs digestion in the widest sense, a role the tradition has described for more than 2,000 years. It transforms food and drink into the Qi and Blood the body is built and run on. Good nourishment, in this view, is a working digestion turning whole food into usable vitality. Both put diet first: each looks to the strength of digestion and treats a concentrated supplement as cover for a single shortfall, useful only where the diet leaves one.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
High-dose beta-carotene raised lung cancer 18% in male smokers (ATBC)
The Alpha-Tocopherol, Beta Carotene (ATBC) Cancer Prevention Study randomized 29,133 male smokers aged 50 to 69 in Finland to beta-carotene (20 mg/day), vitamin E, both, or placebo, for 5 to 8 years. Unexpectedly, men receiving beta-carotene had an 18% higher incidence of lung cancer (95% CI 3% to 36%) and 8% higher total mortality (95% CI 1% to 16%), driven by more deaths from lung cancer and ischemic heart disease. Vitamin E showed no benefit for lung cancer. The dose was far above what a standard multivitamin contains, and the harm was specific to smokers, but it established that a single antioxidant at high dose can do harm where it was expected to protect.ATBC Study Group 1994, N Engl J Med
Beta-carotene plus vitamin A raised lung cancer 28% in smokers and asbestos workers (CARET)
The Beta-Carotene and Retinol Efficacy Trial (CARET) randomized 18,314 smokers, former smokers and asbestos-exposed workers to beta-carotene (30 mg/day) plus vitamin A (retinyl palmitate) or placebo. After a mean 4 years, the active group had a relative risk of lung cancer of 1.28 (95% CI 1.04 to 1.57, P=0.02), death from any cause of 1.17 (95% CI 1.03 to 1.33), and death from lung cancer of 1.46 (95% CI 1.07 to 2.00). The trial was stopped 21 months early. CARET replicated the ATBC finding in a mixed-sex, high-risk population, cementing that high-dose beta-carotene is harmful in people at elevated lung cancer risk.Omenn 1996, N Engl J Med (CARET)
It is not a substitute for food
A multivitamin supplies isolated vitamins and minerals. It lacks the fiber and phytochemicals of whole food. Those appear to carry much of the benefit of eating well. It covers a specific shortfall; it does not replace meals.
Avoid standalone high-dose beta-carotene if you smoke
The harm signal in the research is specific to large doses of single antioxidants, above all beta-carotene, in people who smoke or have had heavy asbestos exposure. In the smoking trials, that meant about 20–30 mg of standalone beta-carotene a day: many times what a multivitamin carries. If you smoke or used to, skip separate high-dose beta-carotene or vitamin A pills.
Iron and the fat-soluble upper limits
Men and postmenopausal women rarely need extra iron and can slowly build up too much. An iron-free formula is usually the better choice for them, unless a clinician has found a need. The fat-soluble vitamins A and D can build up in the body. Keep each near its daily requirement, and do not add separate high-dose A or D pills on top of the multivitamin.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Should everyone take a daily multivitamin?
In the large trials, a well-nourished adult gains little from a daily multivitamin, a varied diet already delivers close to 100% of what the pill contains. Where the body is short of a nutrient, that changes: the pill fills a gap.
Do multivitamins prevent cancer or heart disease?
There is a real distinction between preventing disease and treating a deficiency. Correcting a diagnosed shortfall (iron-deficiency anemia, or a B12 deficiency) fixes something measurable, because a genuine deficit exists to close. A body that already holds enough of a nutrient has nothing for the pill to correct.
Can a multivitamin improve memory?
Possibly, this is the open question. Two recent trials, COSMOS-Mind and COSMOS-Web, reported a small gain in memory and global cognition in older adults on a daily multivitamin. COSMOS-Web put the size at about 3.1 years of age-related memory change. An earlier trial in older male physicians found no such benefit, so the signal is new and unconfirmed. Larger trials are underway.
Who benefits from a multivitamin?
Whoever is short of a nutrient the pill supplies. Often the gap is one specific nutrient: a vegan's shortfall is usually B12, which a single B12 supplement covers directly.
Are multivitamins safe?
At everyday doses, yes, the ordinary multivitamin has more than 20 years of safe use behind it. The risks that matter come from separate high-dose single-nutrient pills, and from stacking those on top of a multivitamin, not from the blend itself.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 12 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.